SEC Company Response from CEL SCI CORP (CVM) (CIK 0000725363) (CVM) — Apr 20, 2015
CEL SCI CORP (CVM) (CIK 0000725363)
Date: April 20, 2015 · CIK: 0000725363 · Accession: 0001004878-15-000108
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-11889
Referenced dates: March 27, 2015
Letter
Re: CEL-SCI Corporation Form 10-K for Fiscal Year Ended September 30, 2014 Filed December 23, 2014 File No. 001-11889
HART & HART, LLC ATTORNEYS AT LAW 1624 Washington Street Denver, CO 80203 William T. Hart, P.C. ________ harttrinen@aol.com Will Hart (303) 839-0061 Fax: (303) 839-5414
April 20, 2015
Johnny Gharib Securities and Exchange Commission 100 F Street, NE Washington, DC 20549
This office represents CEL-SCI Corporation (the "Company"). This letter provides the Company's responses to the comments received from the staff by letter dated March 27, 2015. The paragraph numbers in this letter correspond with the numbered paragraphs in the staff's comment letter. The numbers under the "Page No." column refer to the pages in the Company's amended 10-K report where the Company's response to the particular comment can be found.
Page No.
1. Comment complied with. We believe the Company's disclosure regarding its patents complies with Item 101(c) (iv) of Regulation S-K and is consistent with that of other issuers in the biotech industry. 7
2. Comment complied with. 5
3. Comment complied with. 6, 23
4. Comment complied with. 18, 19
5. Comment complied with. 19
6. Comment complied with. 20
<PAGE>
If you should have any questions concerning the foregoing, please do not hesitate to contact the undersigned.
Very Truly Yours,
HART & HART, LLC
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
HART & HART, LLC
ATTORNEYS AT LAW
1624 Washington Street
Denver, CO 80203
William T. Hart, P.C. ________ harttrinen@aol.com
Will Hart (303) 839-0061
Fax: (303) 839-5414
April 20, 2015
Johnny Gharib
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Re: CEL-SCI Corporation
Form 10-K for Fiscal Year Ended September 30, 2014
Filed December 23, 2014
File No. 001-11889
This office represents CEL-SCI Corporation (the "Company"). This letter
provides the Company's responses to the comments received from the staff by
letter dated March 27, 2015. The paragraph numbers in this letter correspond
with the numbered paragraphs in the staff's comment letter. The numbers under
the "Page No." column refer to the pages in the Company's amended 10-K report
where the Company's response to the particular comment can be found.
Page No.
1. Comment complied with. We believe the Company's disclosure
regarding its patents complies with Item 101(c) (iv) of
Regulation S-K and is consistent with that of other issuers
in the biotech industry. 7
2. Comment complied with. 5
3. Comment complied with. 6, 23
4. Comment complied with. 18, 19
5. Comment complied with. 19
6. Comment complied with. 20
<PAGE>
If you should have any questions concerning the foregoing, please do not
hesitate to contact the undersigned.
Very Truly Yours,
HART & HART, LLC
/s/ William T. Hart
By
William T. Hart
</TEXT>
</DOCUMENT>